# DESCRIPTION

## CROSS REFERENCE

- claim benefit of provisional patent application

## FIELD OF THE INVENTION

- define field of invention

## BACKGROUND OF THE INVENTION

- introduce chronic inflammatory disease
- describe diet and lifestyle issues
- explain glucose and ketone bodies
- discuss calorie restriction
- describe oxidative stress
- explain therapeutic effects of CR
- discuss periodic water-only fasting
- describe ketogenic diet
- explain energy transition
- discuss therapeutic benefits of KD
- describe restricted KDs
- discuss cancer management
- explain molecular mechanisms
- describe Warburg effect
- discuss mitochondrial defects
- introduce metabolic therapy

## SUMMARY OF THE INVENTION

- summarize method for managing metabolic treatment

## DETAILED DESCRIPTION OF INVENTION

- introduce metabolic treatment method
- describe therapeutic strategy
- illustrate concept with sample values
- define Glucose Ketone Index (GKI)
- describe GKI calculator
- explain GKI calculation
- provide GKI formula
- describe unit conversion
- explain GKIC software
- describe GKI target value
- track daily GKI values
- plot progress against initial index value
- describe zone of metabolic management
- explain GKI prediction
- describe alternative ketone bodies
- explain acetoacetate measurement
- provide acetoacetate formula
- describe acetone measurement
- provide acetone formula
- describe urinary acetoacetate measurement
- provide urinary acetoacetate formula
- explain noninvasive biomonitoring techniques
- describe potential applications
- explain GKI utility
- describe disease management
- explain therapeutic success
- describe GKI tracking
- explain dietary adjustments
- describe target zone establishment
- explain GKI lowering
- explain GKI increasing
- describe sample calculation
- describe sample values
- illustrate plot of sample values

### Example 1

- introduce GKIC
- estimate GKI for humans and mice with brain tumors
- show relationship between GKI and efficacy of metabolic therapy
- describe first clinical study
- detail patient 1's response to ketogenic diet
- detail patient 2's response to ketogenic diet
- describe second clinical study
- detail patient's response to calorie-restricted ketogenic diet
- describe third study
- detail effects of diets on mouse astrocytoma
- describe fourth study
- detail effects of diets on mouse glioma
- describe fifth study
- detail effects of diet and radiation on mouse glioma
- summarize results of five studies
- show association of GKI with therapeutic action of calorie restriction
- discuss predictive value of GKI for brain cancer management
- discuss other dietary therapies that lower blood glucose and elevate ketone bodies
- describe zone of metabolic management
- discuss neuroprotective properties of ketone bodies
- discuss therapeutic state of maximal metabolic stress on tumor cells
- discuss validation of GKI in mice
- discuss prospective validation of GKIC in humans
- discuss utility of GKI in determining success of dietary therapies
- discuss use of GKI in clinical trials
- criticize recent clinical studies for not measuring both blood glucose and ketone bodies
- discuss importance of measuring both blood glucose and ketone bodies in future studies
- predict optimal management with GKI values approaching 1.0
- discuss potential utility of GKIC for managing other diseases and conditions

